|4Mar 10, 11:44 AM ET

Fox James 4

4 · GenMark Diagnostics, Inc. · Filed Mar 10, 2020

Insider Transaction Report

Form 4
Period: 2020-03-06
Fox James
Director
Transactions
  • Purchase

    Common Stock

    2020-03-06$5.50/sh+9,000$49,50081,085 total(indirect: Penashe Holdings Propriety Limited)
Holdings
  • Common Stock

    161,596
Footnotes (1)
  • [F1]Dr. Fox is an executive director of Penashe Holdings Propriety Limited and may be deemed to have beneficial ownership of these securities, to the extent of any indirect pecuniary interest in his distributive shares therein.

Documents

1 file
  • 4
    wf-form4_158385502269499.xmlPrimary

    FORM 4